Discovering The Ocean’s Potential

PearlBone™ - improving patient outcomes through advanced bone repair

Close-up of white and pink flowers in the foreground with greenery, and a building with a sign reading 'Marine Biomedical' in the background under a clear blue sky

About Marine Biomedical

Advancing regenerative medicine through marine-derived biomaterial innovation.

Marine Biomedical is an Australian biotech and medical device manufacturing company developing next-generation nacre - a natural biomineralising structure that biomimics human bone.


By combining scientific rigour, sustainable sourcing, and advanced manufacturing, we create solutions that support surgeons and improve patient outcomes.


PearlBone™ putty displayed on a pearl shell, illustrating nacre-derived biomaterial for bone regeneration

PearlBone™

Discovering nature’s blueprint for regenerative bone repair.

Nacre and human bone are built from comparable mineral architectures, enabling nacre to naturally support bone regeneration.


Line icon of a shell representing nacre-derived biomaterial used in PearlBone™
Line icon of a shield with checkmark representing quality, safety, and compliance standards
Hand holding a sprouting plant with two leaves inside a circular arrow.

Marine

Safe

Sustainable

Preparation of PearlBone™ biomaterial samples in a controlled laboratory setting

UNITING SUSTAINABILITY WITH MEDICAL SCIENCE

Marine Biomedical transforms nacre (a naturally occurring biomineral from Western Australia’s pearling industry) into high-value regenerative materials.


Using proprietary knowledge, we developed a biocompatible product that mimics human trabecular bone.

Controlled cleanroom environment with staff-only access for biomaterial handling and processing

PRECISION-ENGINEERED BIOMATERIALS

Our research focuses on nacre-derived bone graft technologies designed to support bone regeneration and integration with native bone in complex orthopaedic and trauma settings.


With a commitment to scientific validation and regulatory rigour, Marine Biomedical is developing the next generation of regenerative solutions for surgeons and their patients.

Opening quotation mark graphic used for testimonial or highlighted statement

Based on the data presented, PearlBone™ Putty was resorbed and replaced by new immature woven cancellous bone in a manner similar to the comparison predicate device which has been used extensively in clinical procedures over the past 20 years. There were no adverse tissue reactions in either group over the 3-month study period. Resorption of the material, new woven bone formation, and remodelling were comparable for both materials

Closing quotation mark graphic used for testimonial or highlighted statement
Professor Goodman, Medical Adviser supporting clinical development at Marine Biomedical

- Professor Stuart B Goodman MD PhD FRCSC FACS FBSE FIOR FORS.  Robert  L. and Mary Ellenburg Professor of Surgery, Professor, Department of Orthopaedic Surgery and (by courtesy) Bioengineering
Stanford University Medical Center Outpatient Center

Gloved hands holding PearlBone™ biomaterial sample in a controlled setting
White right arrow on black background
Close-up of PearlBone™ granules illustrating biomaterial structure
White right arrow pointing to the right on a black background.
Close-up of PearlBone™ biomaterial pieces on a clean white surface

Turning Marine By product into Medical Innovation.

Turning Marine By product into Medical Innovation.

Marine Biomedical transforms pearling by-products into high-value medical materials through a refined circular process. Oyster shells are sustainably sourced, carefully cleaned, and processed to isolate nacre’s unique regenerative structure. This biomineral is then converted into PearlBone™ — a sterile, clinically engineered scaffold designed to support safe, natural bone healing. This approach not only supports sustainability but also transforms an under-utilised marine resource into a breakthrough biomedical innovation.

Marine Biomedical is proud to repurpose an under-utilised, sustainable marine by-product into a breakthrough medical device designed to advance the next generation of bone substitute materials.

 Latest News